Evidence for current treatment options for de novo and recurrent glioblastoma, indications for local and topical therapies, immunotherapy, gene therapy, nanotherapy, small-molecule inhibition, electric tumor treating field stimulation, and antiangiogenic therapies and the role of Avastin.
Recent advances relating to tumor resection, such as stereotactic laser ablation, diffusion tensor imaging, and fluorescent markers.
Prognostic molecular and genetic markers and the impact of gene mutations on survival, as well as controversies relating to pseudo-progression.
Lessons learned from unsuccessful interventions, as well as the most promising aspects of future glioblastoma research and treatment.
Expert Consult eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, and references from the book on a variety of devices.

The story of glioblastoma: history and modern correlates
Epidemiology of glioblastoma and trends in survivorship
The molecular pathogenesis of glioblastoma
Standard of care treatment: How we got here and the evidence behind current regimens
Recurrent Glioblastoma
Principles of surgical treatment
Intraoperative imaging of glioblastoma
Awake craniotomy for glioblastoma
Chemotherapeutics and their efficacy
Radiographic detection and advanced imaging
Principles and tenets of radiation treatment
Local and topical treatment of glioblastoma
Genetically modified T-cell therapy for glioblastoma
Anti-angiogenic therapy
Electric tumor treating field stimulation
Prognostic molecular and genetic markers
Glioblastoma in the elderly
Socioeconomics and survival
Quality of life after glioblastoma treatment
Early detection of glioblastoma
Brain plasticity and reorganization after glioma resection
Minimally invasive targeted therapy
Lessons learned: Clinical trials and other interventions for glioblastoma
The future: anticipating factors necessary for increasing survival after diagnosis